STM Journals Peer-reviewed research from Consortium e-Learning Network

International Journal of Biomedical Innovations and Engineering Original Research

Biomedical Approach to Developing and Characterizing Chitosan Nanoparticles Encapsulating Urapidil for Hypertension Management

  1. V. Tulasi Department of Pharmaceutics, SSJ College of Pharmacy, Hyderabad
  2. A. Saritha Department of Pharmaceutics, SSJ College of Pharmacy, Hyderabad

Abstract

The aim of this study was to create Chitosan Nanoparticles loaded with Urapidil to achieve controlled drug release, enhance solubility, and reduce dosing frequency to improve patient adherence to therapy for hypertension. Urapidil was formulated into nanoparticles via the ionic-gelation method using Chitosan as a polymer, Sodium tripolyphosphate as a cross-linking agent, and filled into hard gelatin capsules after lyophilization. Pre-formulation studies, including melting point analysis and determination of the absorption maximum at 268 nm, confirmed the drug and excipients' stability, safety, and effectiveness within the specified range. Urapidil-loaded chitosan nanoparticles were prepared using various concentrations of chitosan (0.1%, 0.15%, 0.2%, 0.25%, 0.3%, 0.4%, and 0.5%), with sodium tripolyphosphate serving as a cross-linking agent and Tween 80 acting as a de-aggregating agent. Characterization of all seven formulations revealed a percentage yield within the range of 78.84 to 87.25% and entrapment efficiency between 83.40 and 93.15%, with higher concentrations of polymer resulting in increased entrapment efficiency. Solubility analysis showed improvement after formulation, with the solubility of formulation F5 increased to 9.4933 mg/ml in distilled water and 13.251 mg/ml in phosphate buffer pH 6.8. In vitro release studies demonstrated controlled release with formulation F5 releasing 95.03% of the drug after 12 h. This formulation was selected as the optimized one due to its higher entrapment efficiency, drug content, and prolonged drug release profile. Accelerated stability tests revealed no notable changes in the appearance, drug content, or entrapment efficiency of formulation F5 after 90 days under various storage conditions. Among all formulations, F5, with a 0.3% chitosan concentration, proved to be the most effective for achieving controlled drug release.

Keywords

References (20)

  1. Gaur M, Misra C, Yadav AB, Swaroop S, Maolmhuaidh FÓ, Bechelany M, et al. Biomedical Applications of Carbon Nanomaterials: Fullerenes, Quantum Dots, Nanotubes, Nanofibers, and Graphene. Materials. 2021;14(20):5978. doi:10.3390/ma14205978
  2. Barhoum A, Pal K, Rahier H, Uludag H, Kim IS, Bechelany M. Nanofibers as new-generation materials: From spinning and nano-spinning fabrication techniques to emerging applications. Applied Materials Today. 2019;17:1-35. doi:10.1016/j.apmt.2019.06.015
  3. Jeevanandam J, Barhoum A, Chan YS, Dufresne A, Danquah MK. Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein Journal of Nanotechnology. 2018;9:1050-1074. doi:10.3762/bjnano.9.98
  4. Barhoum A, El-Maghrabi HH, Nada AA, Sayegh S, Roualdes S, Renard A, et al. Simultaneous hydrogen and oxygen evolution reactions using free-standing nitrogen-doped-carbon–Co/CoO x nanofiber electrodes decorated with palladium nanoparticles. Journal of Materials Chemistry A. 2021;9(33):17724-17739. doi:10.1039/d1ta03704h
  5. Prasad S., Kumar V., Kirubanandam S., Barhoum A. Emerging Applications of Nanoparticles and Architecture Nanostructures: Current Prospects and Future Trends. Elsevier Inc.; Amsterdam, The Netherlands: 2018. Engineered nanomaterials: Nanofabrication and surface functionalization; pp. 305–340. [CrossRef] [Google Scholar]
  6. Cremers V, Rampelberg G, Barhoum A, Walters P, Claes N, Oliveira TMD, et al. Oxidation barrier of Cu and Fe powder by Atomic Layer Deposition. Surface and Coatings Technology. 2018;349:1032-1041. doi:10.1016/j.surfcoat.2018.06.048
  7. Hammani S, Moulai-Mostefa N, Samyn P, Bechelany M, Dufresne A, Barhoum A. Morphology, Rheology and Crystallization in Relation to the Viscosity Ratio of Polystyrene/Polypropylene Polymer Blends. Materials. 2020;13(4):926. doi:10.3390/ma13040926
  8. Barhoum A, Van Lokeren L, Rahier H, Dufresne A, Van Assche G. Roles of in situ surface modification in controlling the growth and crystallization of CaCO3 nanoparticles, and their dispersion in polymeric materials. Journal of Materials Science. 2015;50(24):7908-7918. doi:10.1007/s10853-015-9327-z
  9. Rehan M, Barhoum A, Khattab TA, Gätjen L, Wilken R. Colored, photocatalytic, antimicrobial and UV-protected viscose fibers decorated with Ag/Ag2CO3 and Ag/Ag3PO4 nanoparticles. Cellulose. 2019;26(9):5437-5453. doi:10.1007/s10570-019-02497-8
  10. Abdel‐Haleem FM, Salah A, Rizk MS, Moustafa H, Bechelany M, Barhoum A. Carbon‐based Nanosensors for Salicylate Determination in Pharmaceutical Preparations. Electroanalysis. 2019;31(4):778-789. doi:10.1002/elan.201800728
  11. Abdel-Haleem FM, Mahmoud S, Abdel-Ghani NET, El Nashar RM, Bechelany M, Barhoum A. Polyvinyl Chloride Modified Carbon Paste Electrodes for Sensitive Determination of Levofloxacin Drug in Serum, Urine, and Pharmaceutical Formulations. Sensors. 2021;21(9):3150. doi:10.3390/s21093150
  12. Abdel-Haleem FM, Gamal E, Rizk MS, Madbouly A, El Nashar RM, Anis B, et al. Molecularly Imprinted Electrochemical Sensor-Based Fe2O3@MWCNTs for Ivabradine Drug Determination in Pharmaceutical Formulation, Serum, and Urine Samples. Frontiers in Bioengineering and Biotechnology. 2021;9. doi:10.3389/fbioe.2021.648704
  13. Mehrotra P. Biosensors and their applications – A review. Journal of Oral Biology and Craniofacial Research. 2016;6(2):153-159. doi:10.1016/j.jobcr.2015.12.002
  14. Rasouli R, Barhoum A, Uludag H. A review of nanostructured surfaces and materials for dental implants: surface coating, patterning and functionalization for improved performance. Biomaterials Science. 2018;6(6):1312-1338. doi:10.1039/c8bm00021b
  15. Rasouli R, Barhoum A, Bechelany M, Dufresne A. Nanofibers for Biomedical and Healthcare Applications. Macromolecular Bioscience. 2018;19(2). doi:10.1002/mabi.201800256
  16. Singh KR, Nayak V, Singh J, Singh AK, Singh RP. Potentialities of bioinspired metal and metal oxide nanoparticles in biomedical sciences. RSC Advances. 2021;11(40):24722-24746. doi:10.1039/d1ra04273d
  17. Tan K.X., Barhoum A., Pan S., Danquah M.K. Emerging Applications of Nanoparticles and Architecture Nanostructures: Current Prospects and Future Trends. Elsevier Inc.; Amsterdam, The Netherlands: 2018. Risks and toxicity of nanoparticles and nanostructured materials; pp. 121–139. [CrossRef] [Google Scholar]
  18. Kim D, Kim J, Park YI, Lee N, Hyeon T. Recent Development of Inorganic Nanoparticles for Biomedical Imaging. ACS Central Science. 2018;4(3):324-336. doi:10.1021/acscentsci.7b00574
  19. Mihai MM, Dima MB, Dima B, Holban AM. Nanomaterials for Wound Healing and Infection Control. Materials. 2019;12(13):2176. doi:10.3390/ma12132176
  20. Said MM, Rehan M, El-Sheikh SM, Zahran MK, Abdel-Aziz MS, Bechelany M, et al. Multifunctional Hydroxyapatite/Silver Nanoparticles/Cotton Gauze for Antimicrobial and Biomedical Applications. Nanomaterials. 2021;11(2):429. doi:10.3390/nano11020429